BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 24418029)

  • 1. [Efficiency of O'Leary-Sant symptom index and problem index in the diagnosis of interstitial cystitis].
    Xu L; Zhang P; Zhang N; Yang Y; Wu ZJ; Zhang CH; Zhang XD
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3347-50. PubMed ID: 24418029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of questionnaires used to screen for interstitial cystitis.
    Kushner L; Moldwin RM
    J Urol; 2006 Aug; 176(2):587-92. PubMed ID: 16813894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.
    Huang MC; Hsieh CH; Chang WC; Chang ST; Lee MS
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):718-721. PubMed ID: 30342658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between 2 interstitial cystitis symptom instruments.
    Sirinian E; Azevedo K; Payne CK
    J Urol; 2005 Mar; 173(3):835-40. PubMed ID: 15711285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
    Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
    Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to initiation of pentosan polysulfate sodium treatment after interstitial cystitis diagnosis: effect on symptom improvement.
    Nickel JC; Kaufman DM; Zhang HF; Wan GJ; Sand PK
    Urology; 2008 Jan; 71(1):57-61. PubMed ID: 18242365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.
    Bosch PC
    J Urol; 2014 Jan; 191(1):77-82. PubMed ID: 23792149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Painful bladder syndrome in interstitial cystitis: relation between symptoms, endoscopy and biopsia results and the treatment effects].
    Zámecník L; Hanus T; Pavlík I
    Cas Lek Cesk; 2007; 146(10):801-5. PubMed ID: 18020015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
    Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
    BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome.
    Kuo YC; Kuo HC
    Int J Clin Pract; 2013 Sep; 67(9):863-9. PubMed ID: 23952465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
    Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
    Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of symptom scales for interstitial cystitis.
    Propert KJ; Mayer RD; Wang Y; Sant GR; Hanno PM; Peters KM; Kusek JW;
    Urology; 2006 Jan; 67(1):55-9. PubMed ID: 16413332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase II Study of the Efficacy and Safety of the Novel Oral SHIP1 Activator AQX-1125 in Subjects with Moderate to Severe Interstitial Cystitis/Bladder Pain Syndrome.
    Nickel JC; Egerdie B; Davis E; Evans R; Mackenzie L; Shrewsbury SB
    J Urol; 2016 Sep; 196(3):747-54. PubMed ID: 26968644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing urgency in interstitial cystitis/painful bladder syndrome.
    Diggs C; Meyer WA; Langenberg P; Greenberg P; Horne L; Warren JW
    Urology; 2007 Feb; 69(2):210-4. PubMed ID: 17275075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
    Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
    Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The study of diagnosis and treatment of interstitial cystitis].
    Sun ZQ; Qian WQ; Xie DS; Song JD
    Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):659-61. PubMed ID: 16008941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnosis and treatment of interstitial cystitis: report of 16 misdiagnosed cases].
    Jiang XZ; Zhang JW; Xu ZS
    Zhonghua Wai Ke Za Zhi; 2006 Jan; 44(2):108-10. PubMed ID: 16620671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.
    Wu Y; He Y; Qi J; Wang S; Wang Z
    Biomol Biomed; 2024 Jan; 24(1):170-175. PubMed ID: 37819233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of intravesical ozone in interstitial cystitis by the O'Leary-Sant symptom index.
    Pires MV; de Lima CJ; Carvalho HC; Moreira LH; Fernandes AB
    Int Urogynecol J; 2023 Jul; 34(7):1437-1446. PubMed ID: 36242631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.